Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 87,700 shares, a decrease of 12.4% from the December 15th total of 100,100 shares. Based on an average daily trading volume, of 105,200 shares, the short-interest ratio is presently 0.8 days.
Crescent Capital BDC Stock Performance
CCAP traded down $0.02 during trading on Friday, hitting $19.34. 74,403 shares of the stock were exchanged, compared to its average volume of 94,750. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14. Crescent Capital BDC has a 1-year low of $15.91 and a 1-year high of $20.03. The stock has a fifty day moving average price of $19.29 and a two-hundred day moving average price of $18.76. The firm has a market capitalization of $716.74 million, a P/E ratio of 7.58 and a beta of 0.81.
Crescent Capital BDC Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were issued a $0.42 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.69%. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s payout ratio is presently 65.88%.
Hedge Funds Weigh In On Crescent Capital BDC
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the company. Keefe, Bruyette & Woods increased their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a report on Monday, November 25th. LADENBURG THALM/SH SH began coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They set a “buy” rating and a $20.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, Crescent Capital BDC currently has an average rating of “Moderate Buy” and a consensus target price of $19.17.
Get Our Latest Stock Report on Crescent Capital BDC
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Recommended Stories
- Five stocks we like better than Crescent Capital BDC
- The Most Important Warren Buffett Stock for Investors: His Own
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Oilfield Leader SLB: An AI Name You Need to Know
- Best Stocks Under $10.00
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.